Found: 20
Select item for more details and to access through your institution.
Genome-Wide Analyses of Nephrotoxicity in Platinum-Treated Cancer Patients Identify Association with Genetic Variant in RBMS3 and Acute Kidney Injury.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 6, p. 892, doi. 10.3390/jpm12060892
- By:
- Publication type:
- Article
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 4, p. 2048, doi. 10.1245/s10434-022-12969-0
- By:
- Publication type:
- Article
Combined therapy for thyroid squamous cell carcinoma.
- Published in:
- Head & Neck, 2012, v. 34, n. 1, p. 131, doi. 10.1002/hed.21484
- By:
- Publication type:
- Article
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies.
- Published in:
- Drugs, 2023, v. 83, n. 2, p. 159, doi. 10.1007/s40265-022-01828-7
- By:
- Publication type:
- Article
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 551, doi. 10.3390/cancers11040551
- By:
- Publication type:
- Article
Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy.
- Published in:
- Cancers, 2018, v. 10, n. 11, p. 445, doi. 10.3390/cancers10110445
- By:
- Publication type:
- Article
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11031-w
- By:
- Publication type:
- Article
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919838964
- By:
- Publication type:
- Article
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919838964
- By:
- Publication type:
- Article
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
- Published in:
- 2019
- By:
- Publication type:
- journal article
Digital Acrometastasis.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 5, p. 1410, doi. 10.1002/art.39053
- By:
- Publication type:
- Article
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 11, p. 1589, doi. 10.1007/s40262-023-01279-7
- By:
- Publication type:
- Article
Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 1, p. 40, doi. 10.1080/0284186X.2022.2159772
- By:
- Publication type:
- Article
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
- Published in:
- Head & Neck, 2017, v. 39, n. 1, p. 140, doi. 10.1002/hed.24556
- By:
- Publication type:
- Article
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1199-8
- By:
- Publication type:
- Article
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 11, p. 1502, doi. 10.1093/bjs/znad228
- By:
- Publication type:
- Article